Project Grant R01AI189572
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Indiana University Indianapolis a Project Grant totaling $433,303 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 18, 2025, with a completion date of May 31, 2027. The award funds research and development of an innovative mosquito control technology utilizing RNA interference (RNAi)-based gene silencing to combat mosquito-borne infectious diseases. The primary...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University $670,881 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year project (April 1, 2026–March 31, 2031) investigating mechanisms of bacterial infection and host-pathogen interactions. The research focuses on how Anaplasma phagocytophilum (APH), the causative agent of human granulocytic anaplasmosis—a serious tick-borne...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a Project Grant of $439,375 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 19, 2026 through January 31, 2028. The award supports the development of novel female-killing genetic technologies targeting Aedes aegypti mosquitoes, the primary vector for dengue, chikungunya, and zika viruses. Specifically, the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Johns Hopkins University a $2.18 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective November 1, 2025, through October 31, 2029. The research addresses chemosensory mechanisms driving malaria transmission by investigating how the African malaria mosquito Anopheles gambiae uses olfactory cues to identify and locate human hosts. The project...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a Project Grant of $537,861 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This grant supports the development and advancement of pairwise survival analysis statistical methods for studying infectious disease transmission within households and close-contact groups. The research extends existing...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston University Medical Campus a $449,625 Project Grant on July 8, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to advance research on arthropod-borne viral transmission mechanisms. This two-year project, concluding July 7, 2027, will deliver a novel preclinical research model designed to better understand how mosquito feeding and arthropod-mediated...
- Federal Grant Award Summary Texas A&M University System Health Science Center received a $423,125 Project Grant award dated July 17, 2025, from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research extending through June 30, 2027. The project focuses on developing an intein-based QF2 (quinic acid-inducible) system for controllable protein expression in the nervous system of Aedes aegypti...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a Project Grant of $2.54 million under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 8, 2025, with a completion date of August 31, 2029. This research initiative focuses on investigating how desiccation tolerance—the ability of Aedes aegypti mosquitoes to survive in low-humidity environments—affects their...
- Federal Grant Award Summary The University of Washington received a $458,849 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. This research initiative will generate comprehensive scientific knowledge and methodological advances regarding the molecular and cellular mechanisms underlying mosquito blood-detection systems, specifically...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego $588,514 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 21, 2025, with a completion date of June 30, 2030. This project grant funds the development of novel mosquito control technologies targeting Aedes aegypti, a primary vector for disease transmission. The research will generate conditional and female-lethal gene...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University $525,789 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 1, 2026, for a five-year project period concluding March 31, 2031. This Project Grant supports comprehensive research to identify and characterize bacterial isolates and microbial communities that influence male life history traits and mating success in genetically diverse Aedes aegypti mosquitoes. The research directly addresses the practical requirements of Sterile Insect Technique (SIT) and mass rearing programs used for mosquito population control and disease prevention worldwide. The funded research will experimentally colonize mosquitoes with multiple candidate bacterial communities and assess their impact on adult male traits critical to SIT effectiveness, including longevity, flight capacity, mating success, sperm quantity, and the ability to induce female refractoriness to re-mating. The project will evaluate these impacts across genetically differentiated mosquito strains under both laboratory and semi-field conditions, and will investigate B vitamins as a mechanistic determinant of male mosquito-microbe interactions. By improving understanding of how microbiota influence male mosquito performance, this research will generate findings applicable to optimizing mass production protocols, enhancing male competitive ability, and extending field efficacy—thereby improving the success and reducing costs of vector control programs.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $525.8k | 3/27/26 |